Search Results 701-710 of 17786 for Visceral

  1. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Measurable visceral disease (eg, adrenal, kidney, liver, lung, pancreas, spleen), OR; Measurable extrapelvic adenopathy (ie, adenopathy above the aortic ...

  2. Virtual Reality for IBS-C - Mayo Clinic

    ... visceral hyperalgesia. Patients will also be excluded from the study if they do not meet Rome IV criteria for IBS-C. Patients who have a known seizure ...

  3. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Histologically confirmed cutaneous or visceral angiosarcoma, where curative treatment is either not possible or curative modality therapy is declined by the ...

  4. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

    Any contraindication to angiography or selective visceral catheterization. 2. Cone Beam CT (CBCT) or Technetium-99m macroaggregated Albumin (99mTc-MAA) ...

  5. physical activity Archives - Mayo Clinic News Network

    ... visceral fat, lowering levels of certain carcinogens, improving insulin sensitivity and decreasing chronic inflammation, physical activity can potentially ...

  6. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

    Active or newly diagnosed CNS metastases, including meningeal carcinomatosis. 2. Patients with advanced, symptomatic visceral spread, that are at risk of

  7. https://www.mayoclinic.org/arabic_organization_concepts.xml

  8. https://www.mayoclinic.org/chinese_organization_concepts.xml

  9. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  10. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) (MV-s-NAP) in Patients with Metastatic Breast Cancer - Mayo Clinic

    * Clinical or radiographic suspicion of impending visceral crisis due to invasion or compression by tumor * Active infection =\< 5 days prior to registration * ...